Conversely, osteoprotegerin (OPG), also known as osteoclastogenesis inhibitory factor, enhances β-cell proliferation (without promoting differentiation) with a consequent increase in beta-cell mass, resulting in significantly delayed hyperglycemia in diabetic mice [22]. The gene discussed is TNFRSF11B; the disease is Hyperglycemia.